A Double-blind Study of Riluzole Augmentation in Serotonin Reuptake Inhibitor-refractory Obsessive-compulsive Disorder and Depression.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2016
At a glance
- Drugs Riluzole (Primary)
- Indications Depression; Obsessive-compulsive disorders
- Focus Therapeutic Use
- 13 Jan 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jul 2015 Primary endpoint has not been met.
- 07 Jul 2015 Results published in the Journal of Clinical Psychiatry.